Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta de Souza Albernaz

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Artificial Cells, Nanomedicine, and Biotechnology|April 17, 2013
Radiolabelled nanohydroxyapatite with 99mTc: perspectives to nanoradiopharmaceuticals constructionMarta de Souza Albernaz, Carlos Alberto Ospina, Alexandre Malta Rossi, et al.
Pharmaceutical Research|January 7, 2018
Decorated Superparamagnetic Iron Oxide Nanoparticles with Monoclonal Antibody and Diethylene-Triamine-Pentaacetic Acid Labeled with Thechnetium-99m and Galium-68 for Breast Cancer ImagingMarta de Souza Albernaz, Sergio Hiroshi Toma, Jeff Clanton, et al.
American Journal of Therapeutics|January 3, 2019
Polycaprolactone Antimony Nanoparticles as Drug Delivery System for LeishmaniasisAriane de Jesus Sousa-Batista, Cristal Cerqueira-Coutinho, Fagner Santos do Carmo, et al.
Current Radiopharmaceuticals|November 21, 2013
Monoclonal antibodies: application in radiopharmacyThais Braga Ligiero, Marta de Souza Albernaz, Samira Marques de Carvalho, et al.
Current Radiopharmaceuticals|June 26, 2012
Polymeric nanoparticles of FMISO: are nano-radiopharmaceuticals better than conventional ones?Marta de Souza Albernaz, Beatriz Ferreira de Carvalho Patricio, Gilberto Weissmuller, et al.
Journal of Biomedical Nanotechnology|May 9, 2014
Development of novel nanoparticle for bone cancerBeatriz Ferreira de Carvalho Patricio, Marta de Souza Albernaz, Michelle Alvares Sarcinelli, et al.
International Journal of Nanomedicine|January 6, 2017
Anti-MUC1 nano-aptamers for triple-negative breast cancer imaging by single-photon emission computed tomography in inducted animals: initial considerationsFagner Santos do Carmo, Eduardo Ricci-Junior, Cristal Cerqueira-Coutinho, et al.
Journal of Global Antimicrobial Resistance|December 3, 2017
New chalcone compound as a promising antileishmanial drug for an old neglected disease: Biological evaluation using radiolabelled biodistributionAriane de J Sousa-Batista, Cíntia I M Silva Philipon, Marta de Souza Albernaz, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 11, 2015
Nano-Hydroxyapatite Doped with Ho-166 as Drug Delivery System for Bone Cancer Therapy and Diagnosis: Developing a Theragnostic RadiopharmaceuticalsFranciana Maria Rosa da Silva, Julio Cezar de Almeida, Elizabeth Eugenio de Mello Oliveira, et al.
Current Cancer Drug Targets|April 8, 2015
Nanoradiopharmaceuticals for Bone Cancer Metastasis ImagingBianca Feliciano Coelho, Marta de Souza Albernaz, Alexandre Iscaife, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Artificial Cells, Nanomedicine, and Biotechnology|April 17, 2013
Radiolabelled nanohydroxyapatite with 99mTc: perspectives to nanoradiopharmaceuticals constructionMarta de Souza Albernaz, Carlos Alberto Ospina, Alexandre Malta Rossi, et al.
Pharmaceutical Research|January 7, 2018
Decorated Superparamagnetic Iron Oxide Nanoparticles with Monoclonal Antibody and Diethylene-Triamine-Pentaacetic Acid Labeled with Thechnetium-99m and Galium-68 for Breast Cancer ImagingMarta de Souza Albernaz, Sergio Hiroshi Toma, Jeff Clanton, et al.
American Journal of Therapeutics|January 3, 2019
Polycaprolactone Antimony Nanoparticles as Drug Delivery System for LeishmaniasisAriane de Jesus Sousa-Batista, Cristal Cerqueira-Coutinho, Fagner Santos do Carmo, et al.
Current Radiopharmaceuticals|November 21, 2013
Monoclonal antibodies: application in radiopharmacyThais Braga Ligiero, Marta de Souza Albernaz, Samira Marques de Carvalho, et al.
Current Radiopharmaceuticals|June 26, 2012
Polymeric nanoparticles of FMISO: are nano-radiopharmaceuticals better than conventional ones?Marta de Souza Albernaz, Beatriz Ferreira de Carvalho Patricio, Gilberto Weissmuller, et al.
Journal of Biomedical Nanotechnology|May 9, 2014
Development of novel nanoparticle for bone cancerBeatriz Ferreira de Carvalho Patricio, Marta de Souza Albernaz, Michelle Alvares Sarcinelli, et al.
International Journal of Nanomedicine|January 6, 2017
Anti-MUC1 nano-aptamers for triple-negative breast cancer imaging by single-photon emission computed tomography in inducted animals: initial considerationsFagner Santos do Carmo, Eduardo Ricci-Junior, Cristal Cerqueira-Coutinho, et al.
Journal of Global Antimicrobial Resistance|December 3, 2017
New chalcone compound as a promising antileishmanial drug for an old neglected disease: Biological evaluation using radiolabelled biodistributionAriane de J Sousa-Batista, Cíntia I M Silva Philipon, Marta de Souza Albernaz, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 11, 2015
Nano-Hydroxyapatite Doped with Ho-166 as Drug Delivery System for Bone Cancer Therapy and Diagnosis: Developing a Theragnostic RadiopharmaceuticalsFranciana Maria Rosa da Silva, Julio Cezar de Almeida, Elizabeth Eugenio de Mello Oliveira, et al.
Current Cancer Drug Targets|April 8, 2015
Nanoradiopharmaceuticals for Bone Cancer Metastasis ImagingBianca Feliciano Coelho, Marta de Souza Albernaz, Alexandre Iscaife, et al.
Pageof 2